Leader Allergy Nasal (mometasone furoate) NDC 70000-0635

Product information

Brand name (proprietary)

Leader Allergy Nasal

Generic name (nonproprietary)

mometasone furoate

Active ingredients

Mometasone furoate monohydrate — 50 ug/1

Dosage form

Spray, Metered

Route

Nasal

Labeler

Cardinal Health 110, LLC. dba Leader

Product type

Over-the-counter drug

Marketing category

NDA — New Drug ApplicationApplication NDA 215712

Marketing start

Sep 22, 2023

Listing expires

Dec 31, 2026

Other FDA classes

Corticosteroid Hormone Receptor Agonists (Mechanism)Corticosteroid Hormone Receptor Agonists (Mechanism)

Identifiers

Product ID 70000-0635_b06fcce1-b499-4f0d-a125-55d3ed7a3593SPL ID b06fcce1-b499-4f0d-a125-55d3ed7a3593SPL set ID 26f929e8-0759-4584-a0bf-f7709baa6beeRxCUI 1797865UNII MTW0WEG809

Pharmacologic class

Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Nasal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470000063501 followed by a unit qualifier and the quantity Copy

Package 70000-0635-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under NDA 215712

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.